Abstract
The goal of this study was to biologically evaluate a newly synthesized radioiodinated ethyl 1,4-dihydro-7-iodo-4-oxoquinoline-3-carboxylate (EIOQC) as a potential lung scintigraphic agent. EIOQC was synthesized, characterized then radioiodinated via direct electrophilic substitution reaction. Factors affecting the radiochemical purity were studied in details and the biological distribution of the radioiodinated compound was evaluated in normal male Albino mice. EIOQC was successfully synthesized and radioiodinated with high radiochemical purity (96 ± 1.21 %) and in vitro stability up to 48 h. The biological evaluation of radioiodinated EIOQC showed high lung affinity of 21.36 ± 1.73 % injected dose/g organ (% ID/g) at 15 min. This study introduces radioiodinated EIOQC as a novel potential radiopharmaceutical for lung perfusion scintigraphy.
Similar content being viewed by others
References
Soler X, Kerr KM, Marsh JJ, Renner JW, Hoh CK, Test VJ, Morris TA (2012) Respirology 17(1):180–184
Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B (2009) Eur J Nucl Med Mol Imaging 36(8):1356–1370
Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, Sostman HD, Hilson AJ (2012) J Nucl Med Technol 40(1):57–65
Akkas BE, Gokcora N, Atasever T, Yetkin I (2011) Nucl Med Commun 32(12):1179–1184
Yang G, Wang X, Wang Z, Jiang Y, Fu J (2011) Clin Nucl Med 36(11):1029–1030
Gu T, Shi H, Xiu Y, Gu Y (2011) Clin Nucl Med 36(12):e209–e212
Fazio F, Wollmer P (1981) Clin Physiol 1(4):323–337
Mathews JJ, Maurer AH, Steiner RM, Marchetti N, Criner G, Gaughan JP, Coxson HO (2008) J Nucl Med 49(5):771–775
Mariano-Goulart D, Barbotte E, Basurko C, Comte F, Rossi M (2006) Eur J Nucl Med Mol Imaging 33(9):1048–1054
Ariizumi M, Tominaga S (1997) Kaku Igaku 34(9):779–787
Nimmo MJ, Merrick MV, Millar AM (1985) Br J Radiol 58(691):635–636
Rowe IF, Sleight PJ, Gaunt JI, Croft DN (1984) Eur J Nucl Med 9(4):154–156
Stavngaard T, Søgaard LV, Mortensen J, Hanson LG, Schmiedeskamp J, Berthelsen AK, Dirksen A (2005) Eur J Nucl Med Mol Imaging 32(4):448–457
Wu Y, Kotzer CJ, Makrogiannis S, Logan GA, Haley H, Barnette MS, Sarkar SK (2011) Mol Imaging Biol 13(5):923–929
Ogi S, Gotoh E, Uchiyama M, Fukuda K, Urashima M, Fukumitsu N (2009) Jpn J Radiol 27(1):20–24
Kathleen PD (1998) Mosby’s diagnostic and laboratory test reference. Mosby Inc, St. Louis
Xu JH, Qin J, Chen WZ, Jiao J, Wang P, Li JF, Zhang Y, Cheng MH (2012) Clin Nucl Med 37(4):377–379
Bartalena T, Oboldi D, Guidalotti PL, Rinaldi MF, Bertaccini P, Napoli G, Gavelli G (2008) Invest Radiol 43(6):368–373
Klaus Z, Claudia BS, Jörg P, Joachim K (2009) Annals Nucl Med 23(1):1–16
Vijayvergiya R, Mittal BR, Grover A, Hariram V, Bhattacharya A, Singh B (2009) Int J Cardiol 133(1):122–125
Miroslavov AE, Gorshkov NI, Lumpov AL, Yalfimov AN, Suglobov DN, Ellis BL, Braddock R, Smith AM, Prescott MC, Lawson RS, Sharma HL (2009) Nucl Med Biol 36(1):73–79
Lobov SA, King DW, Knox KJ, Senden TJ, Stephens RW (2013) Biomaterials 34:1732–1738
http://medicalcenter.osu.edu/heart/conditions/Pages/Tests/PerfusionLungScan.aspx
Hunt P, Frier M, Johnson AR, Berezenko S, Perkins AC (2006) Eur J Pharm Biopharm 62:26–31
Liu FY, Shiau YC, Kao A, Hsu WH, Wang JJ, Tsai CH (2003) Nucl Med Commun 24(12):1243–1246
Hofman MS, Beauregard JM, Barber TW, Neels OC, Eu P, Hicks RJ (2011) J Nucl Med 52(10):1513–1519
De K, Chandra S, Sarkar B, Ganguly S, Misra M (2010) J Radioanal Nucl Chem 283:621–628
Motaleb MA, El Kolaly MT, Rashed HM, Abd El Bary A (2012) J Radioanal Nucl Chem 292:629–635
Sakr TM (2014) Radiochemistry 56:200–206
Narra VR, Howell RW, Harapanhalli RS, Sastry KS, Rao DV (1992) J Nucl Med 33(12):2196–2201
Wang DM, Kuo JW, Kuo WT, Hsu CF, Wang MH, Chang Y, Lin WJ, Wang JT (2014) J Label Compd Radiopharm 57(3):132–135
Ugolini C, Elisei R, Proietti A, Lupi C, Borrelli N, Viola D, Leocata P, Vitti P, Miccoli P, Toniolo A, Basolo F (2014) Thyroid 24(2):339–346
Zhou Y, Xu X, Sun Y, Wang H, Sun H, You Q (2013) Bioorg Med Chem Lett 23(10):2974–2978
Mitscher LA (2005) Chem Rev 105(2):559–592
Fisher LM, Pan XS (2008) Methods Mol Med 142:11–23
De D, Byers LD, Krogstad DJ (1997) J Heterocyclic Chem 34:315–320
De Mague D, Byers JT, Krogstad DJ (1995) Tetrahedron Lett 36:205–208
De D, Krogstad FM, Byers LD, Krogstad DJ (1998) J Med Chem 41:4918–4926
Greenwood N, Earnshaw A (1997) Chemistry of the elements, 2nd edn. Butterworth Heinemann, Oxford
Rhodes BA (1974) J Nucl Med 4:281
Mostafa M, Motaleb MA, Sakr TM (2010) Appl Radiat Isot 68:1959–1963
Motaleb MA, Sakr TM (2011) J Label Compd Radiopharm 54:597–601
Sakr TM, Motaleb MA, Ibrahim IT (2012) J Radioanal Nucl Chem 292:705–710
El Azony KM (2010) J Radioanal Nucl Chem 285:315–320
Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sjöberg S (2002) Radiochem Acta 90:229–235
Puttaswamy, Sukhdev A, Shubha JP (2009) J Mol Catal A Chem 310:24–33
Puttaswamy, Vaz N (2003) Trans Met Chem 28(4):409–417
Ramalingaiah, Jagadeesh RV, Puttaswamy (2007) J Mol Catal A Chem 265:70–79
Motaleb MA, Moustapha ME, Ibrahim IT (2011) J Radioanal Nucl Chem 289:239–245
Wheldon TE, O’Donoghue JA, Barrett A, Michalowski AS (1991) Radiother Oncol 21(2):91–99
Acknowledgments
The authors are grateful to Prof. Dr. Detlef Geffken for his help in the organic synthesis of EIOQC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakr, T.M., Motaleb, M.A. & Zaghary, W.A. Synthesis, radioiodination and in vivo evaluation of ethyl 1,4-dihydro-7-iodo-4-oxoquinoline-3-carboxylate as a potential pulmonary perfusion scintigraphic radiopharmaceutical. J Radioanal Nucl Chem 303, 399–406 (2015). https://doi.org/10.1007/s10967-014-3299-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-014-3299-3